zo ga eerst eens maar wat lezen over antipsychotica, er zijn zo'n 5000 trials om door te lezen, hier alvast een beginnetje..
1: Honer WG et al. Conceptual and Methodological...[PMID: 17696571]
2: Libov I et al. Efficacy of piracetam in the ...[PMID: 17685739]
3: Amato L et al. Antipsychotic medications for...[PMID: 17636840]
4: Kennedy E et al. Antipsychotic medication for ...[PMID: 17636744]
5: Rathbone J et al. Pimozide for schizophrenia or...[PMID: 17636692]
6: Fenton M et al. Thioridazine for schizophreni...[PMID: 17636691]
7: Daiello LA. Atypical antipsychotics for t...[PMID: 17633594]
8: Gonzalez-Pinto A et al. Epidemiology, diagnosis and m...[PMID: 17630815]
9: Greenberg WM et al. Ziprasidone for schizophrenia...[PMID: 17627670]
10: Keefe RS et al. Effects of olanzapine, quetia...[PMID: 17606658]
11: McEvoy JP et al. Efficacy and tolerability of ...[PMID: 17606657]
12: Tay SE. Compliance therapy: an interv...[PMID: 17601158]
13: Salzman C et al. Schizophrenia symptoms remain...[PMID: 17592928]
14: Berman RM et al. The efficacy and safety of ar...[PMID: 17592907]
15: Kahn RS et al. Efficacy and tolerability of ...[PMID: 17592906]
16: Papakostas GI et al. Augmentation of antidepressan...[PMID: 17592905]
17: Large CH. Do NMDA receptor antagonist m...[PMID: 17591656]
18: Maneesakorn S et al. An RCT of adherence therapy f...[PMID: 17584349]
19: Bateman K et al. Cognitive behavioral therapy ...[PMID: 17579541]
20: Bremer T et al. The pharmacogenetics of lithi...[PMID: 17570738]
21: McIntyre RS et al. A preclinical and clinical ra...[PMID: 17563257]
22: Chakrabarti A et al. Schizophrenia trials in China...[PMID: 17559595]
23: Lipkovich I et al. Weight changes during treatme...[PMID: 17548781]
24: Keefe RS et al. Neurocognitive effects of ant...[PMID: 17548746]
25: Heinrichs RW. Cognitive improvement in resp...[PMID: 17548745]
26: van Os S et al. Lack of bioequivalence betwee...[PMID: 17542352]
27: Leon J et al. A study of genetic (CYP2D6 an...[PMID: 17541883]
28: Mauri MC et al. Ziprasidone outcome and toler...[PMID: 17541882]
29: Milano W et al. Appropriate intervention stra...[PMID: 17526469]
30: Genc Y et al. Comparison of clozapine-amisu...[PMID: 17526456]
31: Daniel DG et al. Efficacy and safety of oral a...[PMID: 17522560]
32: Currier GW et al. Intramuscular aripiprazole in...[PMID: 17522559]
33: Barbui C et al. Factors associated with antip...[PMID: 17519645]
34: Yatham LN et al. A double blind, randomized, p...[PMID: 17519644]
35: Baptista T et al. Similar frequency of abnormal...[PMID: 17519643]
36: Brambilla F et al. Olanzapine therapy in anorexi...[PMID: 17519642]
37: Segal M et al. Prolactin serum levels in par...[PMID: 17519641]
38: Bounthavong M et al. Decision analysis model evalu...[PMID: 17518814]
39: Alphs L et al. Asenapine in the treatment of...[PMID: 17514185]
40: DelBello MP et al. A 12-week single-blind trial ...[PMID: 17503991]
41: Marder SR et al. Aripiprazole effects in patie...[PMID: 17503974]
42: Wunderink L et al. Guided discontinuation versus...[PMID: 17503973]
43: Harrow M et al. Factors involved in outcome a...[PMID: 17502806]
44: Bai YM et al. Pharmacokinetics study for hy...[PMID: 17502783]
45: Baskak B et al. The effectiveness of intramus...[PMID: 17502777]
46: Casademont J et al. Neuroleptic treatment effect ...[PMID: 17502776]
47: Citrome L et al. Pharmacokinetics of aripipraz...[PMID: 17502775]
48: Uehlinger C et al. Increased (R)-methadone plasm...[PMID: 17502774]
49: Beasley CM Jr et al. All-cause treatment discontin...[PMID: 17502771]
50: Zhang XY et al. Association of clozapine-indu...[PMID: 17502770]
51: Syrkin AL et al. [Ischemic heart disease in pa...[PMID: 17495845]
52: Vanover KE et al. The effects of food on the ph...[PMID: 17495279]
53: van Ingen Schenau WJ et al. [Is it time for revision of t...[PMID: 17492582]
54: Bosanac P et al. An open-label study of quetia...[PMID: 17487935]
55: McGlashan TH et al. Recruitment and treatment pra...[PMID: 17483100]
56: O'Connor K et al. Treating delusional disorder:...[PMID: 17479527]
57: Katzman MA et al. Weight gain and psychiatric t...[PMID: 17477874]
58: Sepehry AA et al. Selective serotonin reuptake ...[PMID: 17474817]
59: Brecher M et al. Quetiapine and long-term weig...[PMID: 17474816]
60: Morken G et al. Effects of integrated treatme...[PMID: 17474812]
61: Cornblatt BA et al. Can antidepressants be used t...[PMID: 17474810]
62: Thyssen A et al. Rapidly disintegrating risper...[PMID: 17472821]
63: McIntyre RS et al. Aripiprazole: pharmacology an...[PMID: 17472545]
64: Ellis N et al. Exercise interventions as an ...[PMID: 17472204]
65: Haessler F et al. Zuclopenthixol in adults with...[PMID: 17470962]
66: Rathbone J et al. Chinese herbal medicine for s...[PMID: 17470951]
67: Camicioli R et al. Clinical trials in Parkinson'...[PMID: 17469693]
68: Gaudiano BA et al. Course of illness in psychoti...[PMID: 17468682]
69: Zafonte RD. Brain injury research: lesson...[PMID: 17466721]
70: [No authors listed] Sertindole: new drug. Another...[PMID: 17458045]
71: Farver D. The outpatient use of atypica...[PMID: 17455580]
72: Schule C et al. Mirtazapine monotherapy versu...[PMID: 17455104]
73: Nakonezny PA et al. The relationship between seru...[PMID: 17454518]
74: Tobin ML. Psychopharmacology update: wh...[PMID: 17454294]
75: Kurlan R et al. Quetiapine for agitation or p...[PMID: 17452579]
76: Armenteros JL et al. Risperidone augmentation for ...[PMID: 17450046]
77: Faulkner G et al. Interventions to reduce weigh...[PMID: 17449900]
78: Alonso A et al. Surrogate marker evaluation f...[PMID: 17447943]
79: Yang LP et al. Paliperidone extended release...[PMID: 17447829]
80: Gentile S. Atypical antipsychotics for t...[PMID: 17447826]
81: Gerlach M et al. Therapeutic drug monitoring o...[PMID: 17447177]
82: Cohen S et al. Sexual impairment in psychiat...[PMID: 17447174]
83: Lonergan E et al. Antipsychotics for delirium....[PMID: 17443602]
84: Adams CE et al. Chlorpromazine versus placebo...[PMID: 17443500]
85: Reznik AM et al. [Clinical picture and treatme...[PMID: 17436713]
86: Ozdemir V et al. CYP2D6 genotype in relation t...[PMID: 17429316]
87: Khalili H et al. Effects of risperidone on lip...[PMID: 17426072]
88: Migliardi G et al. Effect of topiramate on plasm...[PMID: 17414943]
89: Peuskens J et al. Metabolic control in patients...[PMID: 17414740]
90: Quintana H et al. An open-label study of olanza...[PMID: 17414684]
91: El-Mallakh RS. Medication adherence and the ...[PMID: 17414683]
92: Paton C et al. Augmentation with a second an...[PMID: 17414246]
93: Becker ME et al. A placebo-controlled trial of...[PMID: 17414245]
94: Gorus E et al. The influence of galantamine ...[PMID: 17414243]
95: Zimbroff DL et al. Management of acute agitation...[PMID: 17414241]
96: Tamayo JM et al. Outcomes for Latin American v...[PMID: 17414234]
97: Menza MA et al. An open-label trial of aripip...[PMID: 17414231]
98: Shi L et al. Characteristics and use patte...[PMID: 17412849]
99: Di Michele V et al. [First episode psychoses: psy...[PMID: 17405662]
100: Scherk H et al. Second-generation antipsychot...[PMID: 17404121]
101: Soumerai SB et al. Cost-effectiveness of schizop...[PMID: 17403984]
102: Mizrahi R et al. Adverse subjective experience...[PMID: 17403977]
103: Stroup TS. Heterogeneity of treatment ef...[PMID: 17403379]
104: Goldstein DB et al. Potential genetic causes of h...[PMID: 17403378]
105: Ciudad A et al. [Safety and tolerability of o...[PMID: 17401781]
106: Fitzgerald PB et al. A preliminary fMRI study of t...[PMID: 17398078]
107: Royall DR. Catie's lessons....[PMID: 17397456]
108: Xiang YT et al. Exploring the clinical and so...[PMID: 17397098]
109: Linden M et al. The differentiation between '...[PMID: 17396050]
110: [No authors listed] Antipsychotic drugs: the cost...[PMID: 17390404]
111: Soares-Weiser K et al. Tardive dyskinesia....[PMID: 17390261]
112: Skelly T et al. Is rs7566605, a SNP near INSI...[PMID: 17389899]
113: Stachnik JM et al. Use of atypical antipsychotic...[PMID: 17389666]
114: CME Institute of Physicians Postgraduate Press, Inc. New developments in the treat...[PMID: 17388719]
115: Caroff SN et al. Treatment of tardive dyskines...[PMID: 17388711]
116: Pae CU et al. Rapid versus conventional ini...[PMID: 17388709]
117: Lindenmayer JP et al. A randomized controlled trial...[PMID: 17388705]
118: Howes OD et al. Sexual function and gonadal h...[PMID: 17388704]
119: Leucht S et al. Early prediction of antipsych...[PMID: 17388703]
120: Zhang ZJ et al. Huperzine A as add-on therapy...[PMID: 17383858]
121: Holzhausen SP et al. Use of risperidone in childre...[PMID: 17382594]
122: Mahatthanatrakul W et al. Rifampin, a cytochrome P450 3...[PMID: 17381666]
123: Rea RS et al. Atypical antipsychotics versu...[PMID: 17381385]
124: Velligan DI et al. The reliability and validity ...[PMID: 17379319]
125: Fontenelle LF et al. An update on the pharmacologi...[PMID: 17376013]
126: Ek M et al. [Antipsychotics--clever choic...[PMID: 17375681]
127: Andersen MB et al. The acetylcholinesterase inhi...[PMID: 17374745]
128: Vieta E et al. Evolving trends in the long-t...[PMID: 17366344]
129: Lim HK et al. Amisulpride versus risperidon...[PMID: 17356308]
130: Fick L et al. Long-acting neuroleptics used...[PMID: 17355912]
131: Chouinard S et al. Rivastigmine treatment as an ...[PMID: 17355738]
132: Neovius M et al. Weight development in patient...[PMID: 17355518]
133: Eberhard J et al. Prolactin level during 5 year...[PMID: 17355517]
134: Nasrallah HA. The case for long-acting anti...[PMID: 17355516]
135: [No authors listed] Paliperidone (Invega) for sch...[PMID: 17351558]
136: Dorado P et al. No effect of the CYP1A2*1F ge...[PMID: 17345072]
137: Tramontina S et al. Topiramate in adolescents wit...[PMID: 17343561]
138: Findling RL et al. A 26-week open-label study of...[PMID: 17343549]
139: Thomas P. The stable patient with schiz...[PMID: 17336766]
140: Gharabawi GM et al. A discussion of 2 double-blin...[PMID: 17335334]
141: Carney CE et al. A comparison of rates of resi...[PMID: 17335324]
142: Suresh Kumar PN et al. Melatonin in schizophrenic ou...[PMID: 17335321]
143: Thase ME et al. A randomized, double-blind co...[PMID: 17335320]
144: Kane JM et al. Aripiprazole for treatment-re...[PMID: 17335319]
145: Andreescu C et al. Persisting low use of antipsy...[PMID: 17335316]
146: Rosenheck RA et al. Cost-effectiveness measures, ...[PMID: 17335313]
147: Roessner V et al. Decreased serum activity of s...[PMID: 17333160]
148: Yoshimura M et al. A pharmaco-EEG study on antip...[PMID: 17333135]
149: Naber D et al. Efficacy and safety of risper...[PMID: 17333131]
150: Rico-Villademoros F et al. Confounding by indication and...[PMID: 17329481]
151: Swartz MS et al. Effects of antipsychotic medi...[PMID: 17329467]
152: Stroup TS et al. Effectiveness of olanzapine, ...[PMID: 17329466]
153: Lauriello J. Great(er) expectations....[PMID: 17329458]
154: Marder SR. Lessons from each drug trial....[PMID: 17329457]
155: Costa AM et al. A naturalistic, 9-month follo...[PMID: 17329296]
156: Kerwin R. The House of Commons Health C...[PMID: 17329287]
157: [No authors listed] Alcohol withdrawal syndrome: ...[PMID: 17323538]
158: Freudenreich O et al. Risperidone augmentation for ...[PMID: 17321111]
159: Nickel MK et al. Aripiprazole in treatment of ...[PMID: 17318503]
160: Zhong KX et al. Quetiapine to treat agitation...[PMID: 17316169]
161: Khan A et al. Psychiatric Diagnosis and Cli...[PMID: 17314915]
162: Wang HC et al. Rapid leptin elevation after ...[PMID: 17314489]
163: Wang D et al. Synergistic effect of galanta...[PMID: 17313962]
164: Novick D et al. Symptomatic remission in prev...[PMID: 17310386]
165: Poyurovsky M et al. Attenuating effect of reboxet...[PMID: 17310385]
166: Khazaal Y et al. Cognitive behavioural therapy...[PMID: 17306507]
167: Noe E et al. Efficacy of ziprasidone in co...[PMID: 17297214]
168: Gibson AP et al. Effectiveness and tolerabilit...[PMID: 17293710]
169: Cookson J et al. Number needed to treat and ti...[PMID: 17293709]
170: de Geus F et al. Effects of quetiapine on cogn...[PMID: 17293707]
171: Baptista T et al. Insulin counter-regulatory fa...[PMID: 17293706]
172: Lee SW et al. A 12-week, double-blind, plac...[PMID: 17293705]
173: Wehmeier PM et al. Quality of life and subjectiv...[PMID: 17289237]
174: Xiang YT et al. Clinical and social determina...[PMID: 17289236]
175: [No authors listed] New Alzheimer's clinical tria...[PMID: 17288014]
176: Leucht S et al. Defining 'response' in antips...[PMID: 17287825]
177: Meyer JM. Strategies for the long-term ...[PMID: 17286525]
178: Newcomer JW. Metabolic considerations in t...[PMID: 17286524]
179: Weiden PJ. Discontinuing and switching a...[PMID: 17286523]
180: Nasrallah HA. The roles of efficacy, safety...[PMID: 17286522]
181: Nasrallah HA. Introduction: evaluating the ...[PMID: 17286521]
182: [No authors listed] Practical applications of rec...[PMID: 17284143]
183: Tran-Johnson TK et al. Efficacy and safety of intram...[PMID: 17284138]
184: Karow A et al. Association of subjective wel...[PMID: 17284133]
185: Chan HY et al. Efficacy and safety of aripip...[PMID: 17284127]
186: Seitz DP et al. Antipsychotics in the treatme...[PMID: 17284125]
187: Damier P et al. Bilateral deep brain stimulat...[PMID: 17283284]
188: Ryu S et al. -759 C/T polymorphism of 5-HT...[PMID: 17275977]
189: Fagerlund B et al. Effects of donepezil adjuncti...[PMID: 17272964]
190: de Jonghe JF et al. Early symptoms in the prodrom...[PMID: 17272731]
191: Onor ML et al. Efficacy and tolerability of ...[PMID: 17267378]
192: Vieta E et al. [Vigency of lithium treatment...[PMID: 17266894]
193: Dose M. [Priority for atypical antips...[PMID: 17265252]
194: Abler B et al. Human reward system activatio...[PMID: 17265148]
195: Lim KS et al. Modeling of brain D2 receptor...[PMID: 17259948]
196: Jindal RD et al. Hyperglycemia and diabetes in...[PMID: 17259532]
197: Tunis SL et al. An examination of factors aff...[PMID: 17257471]
198: Mueller SE et al. The impact of self-help group...[PMID: 17255151]
199: Volz A et al. Benzodiazepines for schizophr...[PMID: 17253592]
200: Matar HE et al. Oral fluphenazine versus plac...[PMID: 17253589]
201: Almerie MQ et al. Cessation of medication for p...[PMID: 17253586]
202: Ruddy RA et al. Drama therapy for schizophren...[PMID: 17253555]
203: Jesner OS et al. Risperidone for autism spectr...[PMID: 17253538]
204: Buckley LA et al. Supportive therapy for schizo...[PMID: 17253519]
205: Berner MM et al. Management of sexual dysfunct...[PMID: 17253492]
206: Bagnall A et al. Molindone for schizophrenia a...[PMID: 17253473]
207: Abhijnhan A et al. Depot fluspirilene for schizo...[PMID: 17253464]
208: Hussain HM et al. Atypical antipsychotic drugs ...[PMID: 17251541]
209: Azzaro AJ et al. Selegiline transdermal system...[PMID: 17244765]
210: Lambert M et al. Remission of severely impaire...[PMID: 17244174]
211: Henderson DC et al. A double-blind, placebo-contr...[PMID: 17244173]
212: Denys D et al. Quetiapine addition in obsess...[PMID: 17241831]
213: Raedler TJ et al. Early onset of treatment effe...[PMID: 17239237]
214: Takeuchi T et al. Perospirone in the treatment ...[PMID: 17239041]
215: Arango C et al. A 6-month prospective, observ...[PMID: 17234389]
216: Leweke FM et al. [Efficacy and tolerability of...[PMID: 17230308]
217: De Fruyt J et al. Bipolar (spectrum) disorder a...[PMID: 17230048]
218: Hayman-White K et al. Critique of Falloon and the O...[PMID: 17229274]
219: Troost PW et al. Prolactin release in children...[PMID: 17224713]
220: Gentile S. Extrapyramidal adverse events...[PMID: 17224710]
221: de Leon J et al. Weight gain during a double-b...[PMID: 17224708]
222: Morrens M et al. Psychomotor and memory effect...[PMID: 17224707]
223: Kramer M et al. Paliperidone extended-release...[PMID: 17224706]
224: Godlewska BR et al. [Atypical antipsychotic-induc...[PMID: 17217241]
225: Bartko G et al. [Switching patients with schi...[PMID: 17211055]
226: Sarosi A. [Maintenance pharmacotherapy ...[PMID: 17211053]
227: Bartko G. [New formulations of olanzapi...[PMID: 17211052]
228: Akhondzadeh S et al. Celecoxib as adjunctive thera...[PMID: 17208413]
229: Strous RD et al. Analysis of clinical symptoma...[PMID: 17208382]
230: Gimenez S et al. Effects of olanzapine, risper...[PMID: 17205319]
231: Turner T. Chlorpromazine: unlocking psy...[PMID: 17204765]
232: Smith LA et al. Acute bipolar mania: a system...[PMID: 17201861]
233: Barzman DH et al. The efficacy and tolerability...[PMID: 17201610]
234: Kornischka J et al. [40 years beta-adrenoceptor b...[PMID: 17200914]
235: Ruano G et al. Physiogenomic comparison of w...[PMID: 17199131]
236: Wong J et al. Prolactin, menstrual irregula...[PMID: 17198750]
237: Coyle JT. Substance use disorders and S...[PMID: 17197372]
238: Perlis RH et al. Olanzapine versus risperidone...[PMID: 17196055]
239: Emsley R et al. Remission in first-episode ps...[PMID: 17196049]
240: Akdede BB et al. A double-blind study of combi...[PMID: 17194269]
04-08-11, 02-02-12, 20-06-14, 13-08-15